1. Home
  2. NRXP vs COCH Comparison

NRXP vs COCH Comparison

Compare NRXP & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • COCH
  • Stock Information
  • Founded
  • NRXP 2015
  • COCH 1995
  • Country
  • NRXP United States
  • COCH United States
  • Employees
  • NRXP N/A
  • COCH N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • COCH Blank Checks
  • Sector
  • NRXP Health Care
  • COCH Finance
  • Exchange
  • NRXP Nasdaq
  • COCH Nasdaq
  • Market Cap
  • NRXP 32.6M
  • COCH 31.6M
  • IPO Year
  • NRXP N/A
  • COCH N/A
  • Fundamental
  • Price
  • NRXP $3.05
  • COCH $1.72
  • Analyst Decision
  • NRXP Strong Buy
  • COCH Strong Buy
  • Analyst Count
  • NRXP 4
  • COCH 2
  • Target Price
  • NRXP $28.50
  • COCH $9.25
  • AVG Volume (30 Days)
  • NRXP 188.0K
  • COCH 28.4K
  • Earning Date
  • NRXP 08-13-2025
  • COCH 08-11-2025
  • Dividend Yield
  • NRXP N/A
  • COCH N/A
  • EPS Growth
  • NRXP N/A
  • COCH N/A
  • EPS
  • NRXP N/A
  • COCH N/A
  • Revenue
  • NRXP N/A
  • COCH $212,000.00
  • Revenue This Year
  • NRXP N/A
  • COCH $5.93
  • Revenue Next Year
  • NRXP N/A
  • COCH $17.69
  • P/E Ratio
  • NRXP N/A
  • COCH N/A
  • Revenue Growth
  • NRXP N/A
  • COCH N/A
  • 52 Week Low
  • NRXP $1.10
  • COCH $1.21
  • 52 Week High
  • NRXP $6.01
  • COCH $3.99
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 43.40
  • COCH 60.10
  • Support Level
  • NRXP $3.12
  • COCH $1.56
  • Resistance Level
  • NRXP $3.53
  • COCH $1.80
  • Average True Range (ATR)
  • NRXP 0.16
  • COCH 0.11
  • MACD
  • NRXP -0.07
  • COCH 0.02
  • Stochastic Oscillator
  • NRXP 3.92
  • COCH 60.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.

Share on Social Networks: